Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Oleh Chen"'
Autor:
Melanie Hüther, Oleh V. Stasyk, Claudia Dittfeld, Yuliya Kurlishchuk, Bozhena Vynnytska-Myronovska, Leoni A. Kunz-Schughart, Oleh Chen, Yaroslav Bobak
Publikováno v:
Experimental Cell Research. 341:67-74
Tumor cells rely on a continued exogenous nutrient supply in order to maintain a high proliferative activity. Although a strong dependence of some tumor types on exogenous arginine sources has been reported, the mechanisms of arginine sensing by tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d464f953f3f5901977aeda4e085867d
https://doi.org/10.1016/j.yexcr.2016.01.002
https://doi.org/10.1016/j.yexcr.2016.01.002
Autor:
Iuliia Pavlyk, Maryna Barska, Oksana Mayevska, N. I. Igumentseva, Maria Jolanta Redowicz, Oleh Chen, Liliana Lyniv, Yaroslav Bobak, Yuriy Rzhepetskyy, Olena Karatsai, Oleh V. Stasyk
Publikováno v:
Experimental Cell Research
Anticancer therapy based on recombinant arginine-degrading enzymes has been proposed for the treatment of several types of malignant cells deficient in arginine biosynthesis. One of the predicted side effects of such therapy is restricted bioavailabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa30d80199ccbf52394ef38c04d8d7a
Autor:
Bohdanna Kavalets, Olena I. Vovk, Lilianna Lyniv, Oleh Chen, Oleh V. Stasyk, M. L. Barska, Natalia Sybirna
Publikováno v:
Current Issues in Pharmacy and Medical Sciences. 26:385-389
Recombinant human arginase (rhARG)-based therapy to restrict arginine availability for malignant cells is a promising strategy to treat some cancers, including those of hematological origin. In the present study, we evaluated the action of combined r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6484821f64b8025b5546635610ff40a0
https://doi.org/10.12923/j.2084-980x/26.4/a.07
https://doi.org/10.12923/j.2084-980x/26.4/a.07